Basit öğe kaydını göster

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)

dc.contributor.authorŞenocak Taşçı, Elif
dc.contributor.authorOyan, Başak
dc.contributor.authorSönmez, Özlem
dc.contributor.authorMutlu, Arda Ulaş
dc.contributor.authorAtcı, Muhammed Mustafa
dc.contributor.authorSakin, Abdullah
dc.contributor.authorÖner, İrem
dc.contributor.authorYeşil Çınkır, Havva
dc.contributor.authorKarakurt Eryılmaz, Melek
dc.contributor.authorÇağlayan, Dilek
dc.contributor.authorYazdan Balçık, Onur
dc.contributor.authorPaksoy, Nail
dc.contributor.authorBozkurt, Mustafa
dc.date.accessioned2024-02-02T08:42:26Z
dc.date.available2024-02-02T08:42:26Z
dc.date.issued2024en_US
dc.identifier.citationŞenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atcı, M. M., Sakin, A. ... Bozkurt, M. (2024). Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0en_US
dc.identifier.issn1471-2407
dc.identifier.urihttps://dx.doi.org/10.1186/s12885-024-11863-0
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12240
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the affiliations of authors Başak Oyan, Özlem Sönmez, Leyla Özer, Ali Arıcan, Özlem Er and Mustafa Bozkurt. These authors are all affiliated to institution 2.en_US
dc.language.isoengen_US
dc.publisherBioMed Central Ltden_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectColon Canceren_US
dc.subjectFluouracilen_US
dc.subjectRechallengeen_US
dc.subjectRegorafeniben_US
dc.subjectSurvivalen_US
dc.subjectThird-Line Treatmenten_US
dc.titleCorrection: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)en_US
dc.typeotheren_US
dc.relation.ispartofBMC Canceren_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0003-2538-8569en_US
dc.identifier.volume24en_US
dc.identifier.issue1en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.1186/s12885-024-11863-0en_US
dc.institutionauthorSakin, Abdullah
dc.identifier.scopus2-s2.0-85182828807en_US
dc.identifier.pmid38166764en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
Sakiin-Abdullah-2024.pdf
Boyut:
653.2Kb
Biçim:
PDF
Açıklama:
Tam Metin / Full Text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess